{"input_url":"https://manufacturingchemist.com/fda-panel-backs-six-peptides-for-pharmacy-compounding","gnews_decode":"https://manufacturingchemist.com/fda-panel-backs-six-peptides-for-pharmacy-compounding","http_status":200,"final_url":"https://manufacturingchemist.com/fda-panel-backs-six-peptides-for-pharmacy-compounding","html_length":71965,"trafilatura_result":"ok","text_length":3069,"text_preview":"FDA advisers have recommended that six controversial peptides be added to the US 503A Bulks List — potentially opening the door to broader pharmacy compounding of compounds that have become increasingly popular in the online wellness and longevity space.\nThe Pharmacy Compounding Advisory Committee (","verdict":"OK"}